- Home
- BOLD vs SRXH Comparison
BOLD vs SRXH Comparison
Compare BOLD & SRXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOLD
- SRXH
- Stock Information
- Founded
- BOLD 2018
- SRXH 2013
- Country
- BOLD United States
- SRXH Canada
- Employees
- BOLD N/A
- SRXH N/A
- Industry
- BOLD
- SRXH
- Sector
- BOLD
- SRXH
- Exchange
- BOLD Nasdaq
- SRXH NYSE
- Market Cap
- BOLD 24.4M
- SRXH 7.4M
- IPO Year
- BOLD 2024
- SRXH N/A
- Fundamental
- Price
- BOLD $1.12
- SRXH $0.54
- Analyst Decision
- BOLD Buy
- SRXH
- Analyst Count
- BOLD 3
- SRXH 0
- Target Price
- BOLD $4.00
- SRXH N/A
- AVG Volume (30 Days)
- BOLD 279.9K
- SRXH 564.3K
- Earning Date
- BOLD 08-11-2025
- SRXH 05-15-2025
- Dividend Yield
- BOLD N/A
- SRXH N/A
- EPS Growth
- BOLD N/A
- SRXH N/A
- EPS
- BOLD N/A
- SRXH N/A
- Revenue
- BOLD N/A
- SRXH $119,421,918.00
- Revenue This Year
- BOLD N/A
- SRXH $26.28
- Revenue Next Year
- BOLD N/A
- SRXH $25.00
- P/E Ratio
- BOLD N/A
- SRXH N/A
- Revenue Growth
- BOLD N/A
- SRXH 26.27
- 52 Week Low
- BOLD $1.00
- SRXH $0.47
- 52 Week High
- BOLD $4.72
- SRXH $4.25
- Technical
- Relative Strength Index (RSI)
- BOLD N/A
- SRXH N/A
- Support Level
- BOLD N/A
- SRXH N/A
- Resistance Level
- BOLD N/A
- SRXH N/A
- Average True Range (ATR)
- BOLD 0.00
- SRXH 0.00
- MACD
- BOLD 0.00
- SRXH 0.00
- Stochastic Oscillator
- BOLD 0.00
- SRXH 0.00
About BOLD Boundless Bio Inc. Common Stock
Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.
About SRXH SRX HEALTH SOLUTIONS INC
SRX HealthSolutions Inc is an integrated, Canadian healthcare service provider operating within the specialty healthcare industry. It has developed a collaborative specialty healthcare network (the SRx Network) that strategically positions SRx to achieve business objectives. The SRx Network is comprised of 29 specialty pharmacies, 40 infusion clinics and injection sites, four clinical trials sites, patient support programs (PSP), an allied health team and nursing services, and a wholly owned Health Canada-accredited pharmaceutical wholesale and distribution facility located in Mississauga, Ontario. The SRx Network extends across all 10 Canadian provinces, making it one of the accessible providers of comprehensive, integrated and customized specialty healthcare services in Canada.